EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Design of a Highly Active Peptide Inhibitor of Farnesyltransferase and Its Protective Effect Against Acute Liver Failure

Chun-Lian Huang iD, Hang-Shuai Qu, A-Li Li, Chen-Qian Ying iD, Hui Shao, Yong-Zhi Tang, Hua-Zhong Chen, Tao-Hsin Tung, Jian-Sheng Zhu

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s505541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Chun-Lian Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, 317000, People's…. Hauptthemen laut MEDLINE: Farnesyltranstransferase, Liver Failure, Acute, Enzyme Inhibitors, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FarnesyltranstransferaseLiver Failure, AcuteEnzyme InhibitorsDrug DesignPeptidesProtective AgentsAnimalsMiceHumansMaleDose-Response Relationship, DrugMolecular StructureLipopolysaccharidesStructure-Activity RelationshipApoptosisDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

FTasePANoptosisPD083176(d2,d3,d5)acute liver failurepeptide inhibitor

Substanzen

FarnesyltranstransferaseEnzyme InhibitorsPeptidesLipopolysaccharidesProtective Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, 317000, People's Republic of China.
  • Department of Public Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, 317000, People's Republic of China.
  • Evidence-Based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, 317000, People's Republic of China.

ORCID-Profile: Chun-Lian Huang, Chen-Qian Ying

Zitieren

APA

Huang, C. L., Qu, H. S., Li, A. L., Ying, C. Q., Shao, H., Tang, Y. Z., Chen, H. Z., Tung, T. H., & Zhu, J. S. (2025). Design of a Highly Active Peptide Inhibitor of Farnesyltransferase and Its Protective Effect Against Acute Liver Failure. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s505541

Vancouver

Huang CL, Qu HS, Li AL, Ying CQ, Shao H, Tang YZ, et al. Design of a Highly Active Peptide Inhibitor of Farnesyltransferase and Its Protective Effect Against Acute Liver Failure. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s505541

BibTeX
@article{Huang2025,
  author = {Huang, Chun-Lian and Qu, Hang-Shuai and Li, A-Li and Ying, Chen-Qian and Shao, Hui and Tang, Yong-Zhi and Chen, Hua-Zhong and Tung, Tao-Hsin and Zhu, Jian-Sheng},
  title = {Design of a Highly Active Peptide Inhibitor of Farnesyltransferase and Its Protective Effect Against Acute Liver Failure},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s505541}
}
Kostenlos starten →